#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15818	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2117	743.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1425	1425	C	944	C	860	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29018	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3460	834.6	0	.	n	.	0	T695C	SNP	695	695	T	1036	1036	C	949	C,T	877,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29018	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3460	834.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1678	1678	A	996	A,G	916,5	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29018	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3460	834.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2312	2312	C	893	C,T	808,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29018	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3460	834.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2386	2386	A	893	A	834	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29018	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3460	834.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2938	2938	C	904	C	848	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2198	folP	855	855	100.0	folP.l15.c4.ctg.1	1539	142.1	1	SNP	p	R229S	1	.	.	685	687	AGC	975	977	AGC	232;230;231	A;G;C	214;214;214	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5584	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3369	165.2	1	SNP	p	S91F	1	.	.	271	273	TTC	553	555	TTC	186;185;183	T;T;C	166;168;167	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5584	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3369	165.2	1	SNP	p	D95G	1	.	.	283	285	GGC	565	567	GGC	182;179;178	G;G;C	168;168;164	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5584	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3369	165.2	1	SNP	p	G95N	0	.	.	283	285	GGC	565	567	GGC	182;179;178	G;G;C	168;168;164	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1602	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1425	112.2	1	SNP	p	G45D	0	.	.	133	135	GGC	562	564	GGC	200;204;198	G;G;C	184;185;182	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	896	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1021	87.1	0	.	n	.	0	A197.	DEL	197	197	A	533	533	A	211	A	196	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2814	200.0	1	SNP	p	D86N	0	.	.	256	258	GAC	558	560	GAC	240;238;237	G;A;C	221;215;219	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2814	200.0	1	SNP	p	R87W	0	.	.	259	261	CGT	561	563	CGT	237;241;243	C;G;T	218;222;219	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2814	200.0	1	SNP	p	S87R	1	.	.	259	261	CGT	561	563	CGT	237;241;243	C;G;T	218;222;219	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2814	200.0	1	SNP	p	R87I	0	.	.	259	261	CGT	561	563	CGT	237;241;243	C;G;T	218;222;219	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5656	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2814	200.0	1	SNP	p	S88P	0	.	.	262	264	TCC	564	566	TCC	242;243;243	T;C,A;C,A	222;219,1;220,2	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4530	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2659	169.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1584	1586	GGC	237;235;232	G;G;C	220;219;216	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4258	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2285	185.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1153	1155	GCA	225;224;225	G;C;A	213;209;212	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4258	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2285	185.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1156	1158	ATC	231;232;234	A;T,C;C	214;216,1;218	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4258	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2285	185.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1168	1170	GTG	226;225;222	G;T;G	206;206;203	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4258	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2285	185.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1168	1170	GTG	226;225;222	G;T;G	206;206;203	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4258	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2285	185.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1672	1674	ACC	223;224;226	A;C;C	198;202;204	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4258	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2285	185.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1726	1728	GCG	204;203;200	G;C;G	180;164;168	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4258	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2285	185.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1726	1728	GCG	204;203;200	G;C;G	180;164;168	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4258	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2285	185.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1849	1851	AGC	192;195;191	A;G;C	172;175;173	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4258	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2285	185.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1858	1860	GGC	188;188;189	G;G;C	172;171;171	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4258	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2285	185.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1876	1878	CCG	161;161;164	C,G;C,G;G,C	111,5;114,1;117,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5908	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3149	187.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1737	1739	CCG	218;219;219	C;C;G	190;198;193	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2304	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1781	128.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	612	612	C	182	C	163	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2960	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1473	198.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	403	405	GAA	246;247;249	G;A;A	231;232;236	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2960	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1473	198.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	691	693	GAT	214;212;212	G,A;A;T	199,1;197;198	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2960	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1473	198.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	814	816	TCA	263;263;266	T;C,A;A	252;250,1;254	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2960	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1473	198.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	943	945	GTC	263;261;261	G;T;C	243;240;244	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2960	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1473	198.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1273	1275	GCA	234;233;232	G;C;A	216;214;211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2960	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1473	198.2	1	SNP	p	G120K	1	.	.	358	360	AAG	649	651	AAG	236;232;232	A;A;G	221;219;219	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2960	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1473	198.2	1	SNP	p	D121N	0	.	.	361	363	GAC	652	654	GAC	231;228;226	G;A;C	218;213;216	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2960	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	1473	198.2	1	SNP	p	A121D	1	.	.	361	363	GAC	652	654	GAC	231;228;226	G;A;C	218;213;216	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10950	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4959	220.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	988	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1069	92.1	1	SNP	p	V57M	1	.	.	169	171	ATG	600	602	ATG	217;218;219	A;T;G	203;204;203	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
